§ 18. Mr. Andrew TurnerTo ask the Secretary of State for Health when he expects NICE to publish its guidance on the use of atypical anti-psychotics for people with schizophrenia; and if he will make a statement. [59139]
§ Mr. LammyThe National Institute for Clinical Excellence (NICE) issued guidance on newer atypical anti-psychotics on 6 June 2002. In addition the Department of Health has commissioned NICE to develop a clinical guideline on the management of schizophrenia, to cover treatment by drugs, including atypical anti-psychotics, and psychological therapies. This work is currently in train.
231WDirect ons have been issued obliging health authorities and primary care trusts to provide appropriate funding for recommended treatments. From 1 January 2002, the NHS has three months from the date of publication of each Technology Appraisal Guidance to provide funding, so that clinical decisions made by doctors involving NICE recommended treatments or drugs can be funded.
§ Matthew GreenTo ask the Secretary of State for Health (1) when he expects NICE to publish its guidance on the use of atypical anti-psychotics for people with schizophrenia; and if he will make a statement; [59860]
(2) what plans he has to remove postcode prescribing in relation to atypical anti-psychotics for people with schizophrenia; and if he will make a statement. [59861]
§ Mr. LammyThe National Institute for Clinical Excellence (NICE) issued guidance on newer atypical anti-psychotics on 6 June 2002.
Directions have been issued obliging health authorities and primary care trusts to provide appropriate funding for recommended treatments. From 1 January 2002, the national health service has three months from the date of publication of each technology appraisal guidance to provide funding, so that clinical decisions made by doctors involving NICE recommended treatments or drugs can be funded.